MedTrace Logo

ITBS in MCI and Mild AD

NCT06670820 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2024-11-01

No results posted yet for this study

Summary

This study aims to examine the effects of iTBS on cognitive function in individuals with MCI or mild AD, with a secondary objective of exploring prefrontal TBS mechanisms for cognitive function and the effect of iTBS on BDNF.

Conditions

  • Mild Cognitive Impairment (MCI)
  • Mild Alzheimer Disease

Interventions

DEVICE

Active rTMS

iTBS targeting the left dorsolateral prefrontal cortex (DLPFC) per session, total10 sessions

DEVICE

Sham rTMS

sham iTBS targeting the left dorsolateral prefrontal cortex (DLPFC) per session, total 10 sessions

Sponsors & Collaborators

  • National Defense Medical Center, Taiwan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-31
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06670820 on ClinicalTrials.gov